- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 31, 2025 | 1.77K sh |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $401K |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $333K |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $4.32M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $3.37M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $5.32M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $4.44M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $13.71M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $12.8M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $30.25M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $29.53M |
| Short Term Investments | Q2 2025 · Sep 30, 2024 | $1.1M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 1.77K sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 1.77K sh |
| Capex restated | Q2 2025 · Mar 31, 2024 | $201K |
| Operating Cash Flow restated | Q2 2025 · Mar 31, 2024 | $1.34M |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2024 | $24.08M |
| Stockholders Equity restated | Q2 2025 · Sep 30, 2023 | $24.02M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $10.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $19.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $10.00 |
| Eps Basic restated | Q2 2025 · Mar 31, 2024 | $19.00 |
| Net Income restated | Q2 2025 · Mar 31, 2024 | $17K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | $33K |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$73K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$60K |
| Operating Income | Q2 2025 · Sep 30, 2023 | $537K |
| Operating Income | Q2 2025 · Jun 30, 2023 | $653K |
| Operating Income restated | Q2 2025 · Mar 31, 2023 | −$33K |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $80K |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $167K |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $4.02M |
| Revenue | Q2 2025 · Dec 31, 2023 | $2.09M |
| Revenue | Q2 2025 · Sep 30, 2023 | $2.88M |
| Revenue | Q2 2025 · Jun 30, 2023 | $2.7M |
| Revenue restated | Q2 2025 · Mar 31, 2023 | $2.01M |